Reuters logo
BRIEF-India's Ajanta Pharma Sept-qtr consol profit rises marginally
October 31, 2017 / 7:51 AM / a month ago

BRIEF-India's Ajanta Pharma Sept-qtr consol profit rises marginally

Oct 31 (Reuters) - Ajanta Pharma Ltd:

* Sept quarter consol net profit 1.32 billion rupees versus 1.31 billion rupees year ago

* Sept quarter consol revenue from operations 5.40 billion rupees versus 5.16 billion rupees year ago Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below